Alopecia Market By Type (Androgenic Alopecia, Alopecia Areata, Telogen Effluvium, Traction Alopecia, Scarring Alopecia), By Treatment (Drugs, Oral Medications, Topical Medications, Hair Transplantation, Platelet-Rich Plasma (PRP) Therapy, Laser Therapy, Wigs & Hairpieces), By Age Group (Pediatric, Adult, Geriatric), By End-User (Hospitals, Hair Clinics, Dermatology Clinics, Homecare), By Distribution Channel (Online Retail, Offline Retail, Hospitals & Clinics); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Alopecia Market was valued at USD 7.4 billion in 2023 and will surpass USD 14.2 billion by 2030; growing at a CAGR of 9.7% during 2024 - 2030.

The alopecia market is expanding rapidly as the prevalence of hair loss conditions such as androgenic alopecia, alopecia areata, and telogen effluvium increases globally. With the growing awareness of hair loss treatments and advancements in medical solutions, this market is expected to experience significant growth. The demand for treatments is driven by factors such as an aging population, increased stress levels, and rising beauty standards. Among the various types of alopecia, androgenic alopecia is the most common, influencing the market’s direction, especially with the increasing availability of effective treatments.

Androgenic Alopecia Segment Is Largest Owing to Prevalence

Androgenic alopecia, often referred to as male-pattern baldness or female-pattern hair loss, is the most widespread form of hair loss. It affects both men and women, with a higher prevalence among males. The growth of this segment is driven by the increasing number of people seeking solutions for hereditary hair loss, and the development of advanced treatments such as oral medications, topical therapies, and hair transplants. As one of the most researched types of alopecia, the availability of effective treatment options like minoxidil and finasteride has been pivotal in expanding this segment. This large market segment also benefits from increased consumer awareness and advancements in non-invasive treatments, such as laser therapy and platelet-rich plasma (PRP) therapy.

Hair Transplantation Treatment Is Fastest Growing Owing to Rising Demand

Hair transplantation has emerged as the fastest-growing treatment segment in the alopecia market. The increasing demand for permanent solutions for androgenic alopecia and other types of hair loss has significantly contributed to the popularity of hair transplant procedures. Advancements in surgical techniques, such as follicular unit extraction (FUE) and follicular unit transplantation (FUT), have made the process more effective and less invasive, appealing to a broader demographic. Moreover, hair transplant procedures are increasingly being marketed as a long-term, natural solution to hair loss, further driving demand across the globe. The improvement in technology and surgical practices, combined with a growing preference for lasting results, positions this treatment as a key area of growth in the market.

Adult Age Group Is Largest Owing to Higher Incidence of Hair Loss

The adult age group constitutes the largest segment of the alopecia market, as hair loss typically becomes more prevalent with age. In both men and women, androgenic alopecia typically begins in adulthood, with onset often occurring in the 20s to 30s for men and later in women. This demographic is increasingly seeking treatment options ranging from medical solutions like topical and oral medications to more permanent procedures such as hair transplants. Furthermore, this age group is also driving the demand for cosmetic products like hair wigs and pieces. The significant prevalence of alopecia in this segment, combined with the growing interest in maintaining a youthful appearance, supports the dominance of this group in the overall market.

Hospitals Segment Is Largest Owing to Medical Expertise

The hospitals segment is the largest end-user category in the alopecia market due to the critical role that medical expertise plays in diagnosing and treating severe forms of hair loss. Hospitals offer a wide array of treatment options, including prescription medications, advanced hair transplant surgeries, and PRP therapy. They also have the necessary infrastructure to conduct specialized diagnostic tests that help determine the underlying causes of alopecia. Additionally, hospitals are seen as trustworthy institutions for performing invasive procedures like hair transplants, boosting their dominance in the treatment of alopecia. This segment is expected to continue leading the market as more individuals seek professional medical intervention for advanced hair loss conditions.

Online Retail Channel Is Fastest Growing Owing to Convenience

Online retail is the fastest growing distribution channel in the alopecia market, driven by the increasing popularity of e-commerce and the convenience it offers to consumers. As consumers become more knowledgeable about available products and treatments, online platforms provide easy access to a wide range of products, from topical treatments to wigs and hairpieces. The global shift towards online shopping, combined with the ability to research and compare products, makes online retail a preferred channel for individuals seeking both OTC and prescription hair loss products. The accessibility and variety of choices available through online channels are contributing to the rapid growth of this segment, especially among younger and tech-savvy consumers.

North America Is Largest Region Owing to High Consumer Awareness

North America is the largest regional market for alopecia treatments, driven by a high level of consumer awareness about hair loss treatments, advanced healthcare systems, and the availability of cutting-edge medical solutions. The region’s dominance is attributed to the widespread prevalence of androgenic alopecia, particularly among the aging population. Additionally, North America is home to numerous leading companies in the hair loss treatment space, such as Johnson & Johnson, Procter & Gamble, and other prominent dermatology clinics. With a focus on both preventive and corrective treatments, the North American market is expected to continue to hold a leading position throughout the forecast period.

Competitive Landscape and Leading Companies

The alopecia market is highly competitive, with numerous companies and healthcare providers offering a range of treatment options. Leading players in the market include pharmaceutical companies like GlaxoSmithKline and Procter & Gamble, as well as specialized clinics and treatment providers like Bosley and Aderans. Companies are increasingly focusing on product innovation, including non-invasive solutions like laser therapy devices and PRP therapy, to cater to a wider range of consumers. Partnerships between pharmaceutical companies and dermatology clinics are also becoming more common, as they allow for the integration of advanced treatments with personalized patient care. The competitive landscape is expected to evolve with the growing demand for more effective and accessible hair loss treatments, along with the rising preference for non-invasive options.

Recent Developments:

• Bosley announces the launch of a new hair restoration clinic in New York, expanding its reach in the U.S. market.
• Aderans Medical Research launches a new PRP treatment device for alopecia patients.
• Johnson & Johnson receives FDA approval for a new topical hair loss medication, aimed at androgenic alopecia.
• Procter & Gamble acquires a leading hair care startup focused on hair regrowth solutions.
• Viviscal introduces a new supplement aimed at treating telogen effluvium, expanding its product portfolio

List of Leading Companies:

• Regenera Activa
• Johnson & Johnson
• L’Oréal S.A.
• Procter & Gamble
• GlaxoSmithKline
• Bayer AG
• Rogaine
• Viviscal
• Aclaris Therapeutics
• Hairmax
• Medtronic
• FOLIGAIN
• Revivogen
• Bosley
• Mercury Pharmaceuticals

Report Scope: